TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT05329129: OssDsign® Spine Registry Study ("Propel")

Sponsor: OssDsign · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 450 pts

Competing Trials Overlap

10 Active Trials

Excess Burn Exposure

$5,411,600

Rescue Site Savings

+$3,585,600

Unlock Full NCT05329129 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05329129 Rescue Dossier →